Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?


OverviewRevenueFinancialsChart

Nuvectis Pharma Ownership Summary


Nuvectis Pharma is owned by 17.29% institutional investors, 40.10% insiders, and 42.60% retail investors. Vanguard group is the largest institutional shareholder, holding 3.27% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.50% of its assets in Nuvectis Pharma shares.

NVCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvectis Pharma17.29%40.10%42.60%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group698.71K3.27%$4.21M
Blackrock funding, inc. /de685.34K3.21%$4.13M
Iridian asset management llc/ct405.62K1.90%$2.44M
Baldwin brothers llc/ma350.46K1.64%$2.11M
Geode capital management325.73K1.52%$1.96M
State street136.72K0.64%$823.03K
Blackrock83.41K0.50%$528.00K
Northern trust106.64K0.50%$641.98K
Oppenheimer69.07K0.32%$415.78K
Forbes j m & co llp59.00K0.28%$355.18K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Iridian asset management llc/ct405.62K0.96%$2.44M
Baldwin brothers llc/ma350.46K0.14%$2.11M
Forbes j m & co llp59.00K0.03%$355.18K
Austin wealth management20.13K0.02%$119.14K
Gsa capital partners llp23.45K0.01%$141.00K
Oppenheimer69.07K0.01%$415.78K
Nations financial group inc, /ia/ /adv13.00K0.00%$78.26K
Xtx topco14.87K0.00%$89.49K
Avalon trust10.00K0.00%$60.20K
Edmond de rothschild15.17K0.00%$91.32M

Top Buyers

HolderShares% AssetsChange
Goldman sachs group45.16K-45.16K
Blackrock funding, inc. /de685.34K0.00%42.35K
Geode capital management325.73K0.00%40.40K
Iridian asset management llc/ct405.62K0.96%32.90K
Vanguard group698.71K0.00%31.90K

Top Sellers

HolderShares% AssetsChange
Blackrock83.41K--289.31K
Marshall wace, llp10.69K0.00%-52.92K
Millennium management29.70K0.00%-38.80K
Omers administration---32.88K
Qube research---30.59K

New Positions

HolderShares% AssetsChangeValue
Citadel advisors14.94K-14.94K$94.55K
Xtx topco14.87K0.00%14.87K$89.49K
Avalon trust10.00K0.00%10.00K$60.20K
Tower research capital llc (trc)3.85K0.00%3.85K$23.17K
Russell investments group1.07K-1.07K$6.42K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-1.00
Nbc securities-5.00
Nisa investment advisors-12.00
Point72 (difc)-49.00
Hollencrest capital management-400.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20255519.57%3,694,86214.85%177.63%25-24.24%15114.29%
Jun 30, 20254932.43%3,242,70858.40%1514.40%3650.00%7133.33%
Mar 31, 20253719.35%2,047,14054.99%1017.47%2414.29%3-62.50%
Dec 31, 202430-3.23%1,298,77823.77%720.32%2053.85%8-27.27%
Sep 30, 202431-18.42%1,049,389-12.85%611.52%14-44.00%11-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv357.63K1.50%-7.89K
iShares Russell 2000 ETF261.27K1.03%-
Vanguard Institutional Extnd Mkt Idx Tr130.84K0.55%-64.53K
Fidelity Small Cap Index129.67K0.51%129.67K
iShares Russell 2000 Growth ETF108.20K0.42%-
Vanguard Russell 2000 ETF62.02K0.26%-3.50K
Fidelity Extended Market Index62.26K0.24%-512.00
State St Russell Sm Cap® Indx SL Cl I45.10K0.18%-
Schwab Small Cap Index32.38K0.14%-
NT R2000 Index Fund - NL31.13K0.13%31.13K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 05, 2025BENTSUR RON Chairman & CEOBuy$28.60K
Nov 05, 2025Sanchez Juan-Buy$75.27K
Nov 05, 2025Kaplan Matthew L.-Buy$64.24K
Oct 23, 2025Mosseri Marlio Charles-Buy$284.21K
Oct 24, 2025Mosseri Marlio Charles-Buy$215.46K

Insider Transactions Trends


DateBuySell
2025 Q46-
2025 Q218-
2025 Q11-
2024 Q461
2024 Q3--

NVCT Ownership FAQ


Who Owns Nuvectis Pharma?

Nuvectis Pharma shareholders are primarily institutional investors at 17.29%, followed by 40.10% insiders and 42.61% retail investors. The average institutional ownership in Nuvectis Pharma's industry, Biotech Stocks , is 45.22%, which Nuvectis Pharma falls below.

Who owns the most shares of Nuvectis Pharma?

Nuvectis Pharma’s largest shareholders are Vanguard group (698.71K shares, 3.27%), Blackrock funding, inc. /de (685.34K shares, 3.21%), and Iridian asset management llc/ct (405.62K shares, 1.90%). Together, they hold 8.38% of Nuvectis Pharma’s total shares outstanding.

Does Blackrock own Nuvectis Pharma?

Yes, BlackRock owns 0.50% of Nuvectis Pharma, totaling 83.41K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 528K$. In the last quarter, BlackRock decreased its holdings by -289K shares, a -77.62% change.

Who is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested?

Iridian asset management llc/ct is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 405.62K Nuvectis Pharma shares, valued at 2.44M$.

Who is the top mutual fund holder of Nuvectis Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nuvectis Pharma shares, with 1.50% of its total shares outstanding invested in 357.63K Nuvectis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools